LGND
$295.54-0.99%
Ligand Pharmaceuticals IncorporatedStock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%Russell 3000 0.009%US Stock Market 0.008%
Ligand Pharmaceuticals Incorporated total returns by year (including dividends)
As of market close, Oct 16, 2026
Ligand Pharmaceuticals Incorporated total returns by year (1993–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $189.07 | $295.54 | 0.0% | +56.3% | |
| 2025 | $107.15 | $189.07 | 0.0% | +76.5% | |
| 2024 | $71.42 | $107.15 | 0.0% | +50.0% | |
| 2023 | $66.80 | $71.42 | 0.0% | +6.9% | |
| 2022 | $96.36 | $66.80 | 0.0% | -30.7% | |
| 2021 | $62.04 | $96.36 | 0.0% | +55.3% | |
| 2020 | $65.06 | $62.04 | 0.0% | -4.6% | |
| 2019 | $84.65 | $65.06 | 0.0% | -23.1% | |
| 2018 | $85.42 | $84.65 | 0.0% | -0.9% | |
| 2017 | $63.39 | $85.42 | 0.0% | +34.8% | |
| 2016 | $67.64 | $63.39 | 0.0% | -6.3% | |
| 2015 | $33.19 | $67.64 | 0.0% | +103.8% | |
| 2014 | $32.81 | $33.19 | 0.0% | +1.2% | |
| 2013 | $12.94 | $32.81 | 0.0% | +153.6% | |
| 2012 | $7.40 | $12.94 | 0.0% | +74.7% | |
| 2011 | $5.56 | $7.40 | 0.0% | +33.1% | |
| 2010 | $8.12 | $5.56 | 0.0% | -31.5% | |
| 2009 | $10.26 | $8.12 | 0.0% | -20.8% | |
| 2008 | $18.08 | $10.26 | 0.0% | -43.3% | |
| 2007 | $40.99 | $18.08 | 0.0% | -55.9% | |
| 2006 | $41.73 | $40.99 | 0.0% | -1.8% | |
| 2005 | $43.57 | $41.73 | 0.0% | -4.2% | |
| 2004 | $54.98 | $43.57 | 0.0% | -20.8% | |
| 2003 | $20.10 | $54.98 | 0.0% | +173.6% | |
| 2002 | $67.00 | $20.10 | 0.0% | -70.0% | |
| 2001 | $52.40 | $67.00 | 0.0% | +27.9% | |
| 2000 | $48.19 | $52.40 | 0.0% | +8.7% | |
| 1999 | $43.51 | $48.19 | 0.0% | +10.8% | |
| 1998 | $48.19 | $43.51 | 0.0% | -9.7% | |
| 1997 | $55.68 | $48.19 | 0.0% | -13.4% | |
| 1996 | $40.24 | $55.68 | 0.0% | +38.4% | |
| 1995 | $30.88 | $40.24 | 0.0% | +30.3% | |
| 1994 | $43.98 | $30.88 | 0.0% | -29.8% | |
| 1993 | $39.30 | $43.98 | 0.0% | +11.9% |
- Annualized
- +5.8%
- 1993–2026
- Average year
- +15.9%
- 33 full years
- Best year
- +173.6%
- 2003
- Worst year
- -70.0%
- 2002
- Positive years
- 17/33
- 52% up
Annualized (CAGR)
+5.8%
1993–2026
Average year
+15.9%
33 full years
Best year
+173.6%
2003
Worst year
-70.0%
2002
Positive years
17/33
52% up
Total return by period#
Annual
-150%-100%-50%0%50%100%150%
1993+12%'93
1994-30%
1995+30%
1996+38%'96
1997-13%
1998-9.7%
1999+11%'99
2000+8.7%
2001+28%
2002-70%'02
2003+174%
2004-21%
2005-4.2%'05
2006-1.8%
2007-56%
2008-43%'08
2009-21%
2010-31%
2011+33%'11
2012+75%
2013+154%
2014+1.2%'14
2015+104%
2016-6.3%
2017+35%'17
2018-0.9%
2019-23%
2020-4.6%'20
2021+55%
2022-31%
2023+6.9%'23
2024+50%
2025+76%
2026+56%'26
Methodology#
Total returns, dividends reinvested, measured on LGND. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Ligand Pharmaceuticals Incorporated's average annual return?
- Since 1993, Ligand Pharmaceuticals Incorporated (LGND) has returned about 5.8% a year (the compound annual growth rate) and an average calendar-year return of 15.9%.
- What were Ligand Pharmaceuticals Incorporated's best and worst years?
- Over 1993–2026, the best year was 2003 (+173.6%) and the worst was 2002 (-70.0%).
- How often is Ligand Pharmaceuticals Incorporated up in a year?
- 17 of the 33 full years since 1993 were positive — about 52% of the time.
More on Ligand Pharmaceuticals Incorporated
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100